Table 4.
Details of local -regional recurrence patients
| No. of Patient | Age (years) | Sex | Stage | Site of relapse | Location of the recurrence volume | DVH statistics to recurrence volume | Type of relapse | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Dmean (Gy) |
Dmin (Gy) |
Dmax (Gy) |
V95% (%) | |||||||
| 1 | 48 | Male | T2N2M0 III | Regional | CTV | 66.8 | 65.0 | 73.4 | 100 | In-field |
| 2 | 54 | Male | T4N1M0 IV | Local | GTV | 65.6 | 62.1 | 76.9 | 100 | In-field |
| 3 | 72 | Male | T1N2M0 III | Regional | CTV | 67.3 | 65.1 | 72.2 | 100 | In-field |
| 4 | 79 | Male | T4N1M0 IV | Local | CTV | 64.5 | 60.6 | 71.3 | 100 | In-field |
| 5 | 35 | Male | T4N0M0 IV | Local | Marginal to CTV | 62.5 | 55.1 | 70.3 | 90.2 | marginal |
| 6 | 29 | Male | T2N2M0 III | Local | GTV | 70.2 | 65.7 | 77.5 | 100 | In-field |
| 7 | 36 | Male | T1N2M0 III | Local | GTV | 67.3 | 61.4 | 75.8 | 98.4 | In-field |
| 8 | 32 | Female | T2N2M0 III | Regional | CTV | 71.2 | 67.4 | 78.6 | 100 | In-field |
| 9 | 35 | Male | T4N2M0 IV | Local | CTV | 65.5 | 62.0 | 74.2 | 100 | In-field |
| 10 | 41 | Female | T1N3M0 IV | Local | GTV | 70.5 | 66.8 | 78.4 | 100 | In-field |
| 11 | 52 | Male | T3N0M0 III | Local | CTV | 63.1 | 60.7 | 72.4 | 100 | In-field |
| 12 | 84 | Female | T1N1M0 II | Local | CTV | 64.3 | 60.6 | 69.4 | 100 | In-field |
| 13 | 49 | Female | T1N2M0 III | Local | CTV | 67.8 | 62.6 | 74.5 | 100 | In-field |
| 14 | 70 | Female | T4N2M0 IV | Local | Marginal to CTV | 66.3 | 61.9 | 75.8 | 100 | marginal |
| 15 | 52 | Male | T2N2M0 III | Local | Outside CTV | 64.7 | 59.3 | 72.0 | 99.6 | outside |
| 16 | 70 | Male | T2N2M0 III | Local | CTV | 67.4 | 63.6 | 73.3 | 100 | In-field |
| 17 | 81 | Female | T3N2M0 III | Local | CTV | 70.6 | 65.8 | 78.4 | 100 | In-field |
| 18 | 55 | Male | T2N0M0 II | Local | GTV | 64.3 | 58.8 | 72.5 | 100 | In-field |